A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CTLA-4

Search Conditions:
Search Keyword : CTLA-4
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: CTLA-4
Appearance Frequency: 2666 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
cytotoxic T-lymphocyte-associated protein 4
(1421 times)
Neoplasms
(353 times)
PD-1 (315 times)
PD-L1 (190 times)
ICIs (83 times)
1995 Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.
cytotoxic T-lymphocyte antigen-4
(1160 times)
Allergy and Immunology
(275 times)
PD-1 (205 times)
PD-L1 (95 times)
OR (59 times)
1995 Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
CTL-associated antigen 4
(27 times)
Neoplasms
(14 times)
CTLs (3 times)
TME (3 times)
DC (2 times)
2004 CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria.
cytotoxic T cell antigen 4
(14 times)
Neoplasms
(3 times)
OR (3 times)
PD-1 (2 times)
SNPs (2 times)
2003 Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
CTL antigen 4
(13 times)
Neoplasms
(11 times)
PD-1 (3 times)
PD-L1 (2 times)
CR (1 time)
2003 Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist.
CTL-associated protein 4
(5 times)
Neoplasms
(2 times)
BTLA (2 times)
PD-1 (2 times)
Tim-3 (2 times)
2009 Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
anti-CTL antigen-4
(4 times)
Neoplasms
(4 times)
mAb (2 times)
PD-1 (2 times)
GITR (1 time)
2006 Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.
cytotoxic T lymphocyte Ag-4
(3 times)
Allergy and Immunology
(2 times)
ICI (1 time)
irAE (1 time)
SEB (1 time)
1997 Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
anti-cytotoxic T-lymphocyte 4
(2 times)
Allergy and Immunology
(1 time)
ICI (1 time)
IL (1 time)
IMDC (1 time)
2017 Immune correlates of clinical outcome in melanoma.
10  cell lymphocyte-associated molecule-4
(2 times)
Genetics
(1 time)
ATD (1 time)
HT (1 time)
TRAb (1 time)
2002 Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
11  anti-cytotoxic T-lymphocyte antigen-4 monoclonal
(1 time)
Neoplasms
(1 time)
--- 2014 An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.
12  case of autoimmune hypophysitis induced by the anticytotoxic T-lymphocyte antigen-4
(1 time)
Endocrinology
(1 time)
irAE (1 time)
2015 Anticytotoxic T-lymphocyte antigen-4 induced autoimmune hypophysitis: a case report and literature review.
13  CD28 lead to signaling activation, while T-lymphocyte antigen 4
(1 time)
Allergy and Immunology
(1 time)
PD-1 (1 time)
PI3K (1 time)
2021 Molecular interactions of the CTLA-4 cytoplasmic region with the phosphoinositide 3-kinase SH2 domains.
14  change in the levels of T-lymphocyte-associated antigen 4
(1 time)
Neurosurgery
(1 time)
ELISA (1 time)
GKR (1 time)
PD-L1 (1 time)
2019 Gamma knife radiosurgery compared to whole brain radiation therapy enhances immunity via immunoregulatory molecules in patients with metastatic brain tumours.
15  checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4
(1 time)
ACTH (1 time)
MRI (1 time)
NSCLC (1 time)
2018 Two Cases of Atezolizumab-Induced Hypophysitis.
16  clarify the role of the T-lymphocyte-associated-4
(1 time)
Endocrinology
(1 time)
Ab (1 time)
AITD (1 time)
RFLP (1 time)
2003 Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children.
17  combinations of the following monoclonal antibodies: CD3-PE/cy5, CD4-APC, CD8-APC, CD152-PE
(1 time)
Medicine
(1 time)
CHB (1 time)
PBMCs (1 time)
PD-L1 (1 time)
2013 CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
18  common T lymphocyte antigen 4
(1 time)
Drug Therapy
(1 time)
PD-1 (1 time)
2015 The genetic basis of new treatment modalities in melanoma.
19  CONTENT: T-lymphocyte-associated antigen 4
(1 time)
Communicable Diseases
(1 time)
ESCMID (1 time)
ESGICH (1 time)
mAb (1 time)
2018 ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
20  cytokine suppressors such as T lymphocyte-associated antigen-4
(1 time)
Complementary Therapies
(1 time)
ELISA (1 time)
ICOS (1 time)
IFN-gamma (1 time)
2012 Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
21  cytotoxic T cell associated antigen-4
(1 time)
Chemistry
(1 time)
MAPK (1 time)
MEK (1 time)
PD-L1 (1 time)
2020 Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade.
22  cytotoxic T lymphocyte associated antigen receptor-4
(1 time)
Biomedical Engineering
(1 time)
DC (1 time)
IL-6 (1 time)
SAM (1 time)
2009 Dendritic cell responses to self-assembled monolayers of defined chemistries.
23  Cytotoxic T-cell Associated Protein 4
(1 time)
Hematology
(1 time)
LAG-3 (1 time)
MCL (1 time)
PD-1 (1 time)
2019 Modulation of immune checkpoint molecule expression in mantle cell lymphoma.
24  cytotoxic T-cell-associated Ag-4
(1 time)
Cells
(1 time)
BM-MSCs (1 time)
DT-MSCs (1 time)
GVHD (1 time)
2019 Mesenchymal Stem/Stromal Cells Derived from Dental Tissues: A Comparative In Vitro Evaluation of Their Immunoregulatory Properties Against T cells.
25  cytotoxic T-lymphocyte attenuator-4
(1 time)
Communicable Diseases
(1 time)
LAG-3 (1 time)
PD-1 (1 time)
2015 Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.